Regular paper

Circular RNA CSPP1 motivates renal cell carcinoma carcinogenesis and the Warburg effect by targeting RAC1 through microRNA-493-5p

Dong Zhang, XiaoJie Yang, QiDong Luo, DeLai Fu, HongLiang Li, Peng Zhang
and Chong Tie

Department of Urology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an City, Shaanxi Province, 710004, China

Circular RNAs (circRNAs) take on regulatory roles in renal cell carcinoma (RCC). The research’s goal was to figure out circ-CSPP1’s role and molecular mechanism in RCC. The results clarified that circ-CSPP1 expression was enhanced in RCC. Down-regulating circ-CSPP1 refrained the proliferation, migration, invasion, and Warburg effect (aerobic glycolysis), but accelerated apoptosis of RCC cells. The luciferase activity assay exhibited that circ-CSPP1 could perform as an endogenous sponge for miR-493-5p. Elevating miR-493-5p repressed RCC progression. The bioinformatics website starBase confirmed that ras-related C3 botulinum toxin substrate 1 (RAC1) was a target gene of miR-493-5p. Circ-CSPP1 up-regulated RAC1 by sponging miR-493-5p, and elevating RAC1 could turn around the effect of down-regulating circ-CSPP1 on RCC cells. Taken together, circ-CSPP1 is identified as a novel RCC-promoting RNA that could serve as a latent therapeutic target for RCC therapy.

Keywords: Circ-CSPP1, MiR-493-5p, RAC1; renal cell carcinoma, Warburg effect

Received: 31 March, 2022; revised: 23 May, 2023; accepted: 28 June, 2023; available on-line: 18 September, 2023

e-mail: zpbill013@hotmail.com

Acknowledgements of Financial Support: The National Natural Science Foundation of China (NSFC No.81101937).

Abbreviations: circRNAs, Circular RNAs; HCC, hepatocellular carcinoma; miRNAs, MicroRNAs; RCC, Renal cell carcinoma; RAC1, Ras-related C3 botulinum toxin substrate 1

Introduction

Renal cell carcinoma (RCC) is a class of diversified malignant neoplasms of the renal cortex with diverse clinical, morphological, and genetic features (Rysz et al., 2021). Though clinical interventions like chemotherapy, surgery, and radiotherapy have made great progress, RCC patients’ prognosis is still unpleasing. Therefore, it is imperative to develop new therapeutic strategies considering the biological characteristics of RCC cells. It is well known that metabolic reprogramming, a recognized hallmark of cancer, achieves tumor cell proliferation and survival by changing bioenergetic and biosynthetic pathways. Tumor cells having glycolysis high rates (Warburg effect) is a phenomenon that has been extensively studied in RCC (Emberley et al., 2021). Therefore, figuring out the regulatory mechanism of the Warburg effect is likely to be beneficial for the development of effective RCC treatments.

Circular RNAs (circRNAs), a class of covalently closed endogenous RNAs without a 5’ cap or 3’ poly(A) tail, are cell-specific, tissue-specific, and developmental stage-specific (Huang et al., 2020). For a long time, circRNAs have been regarded as waste products of splicing errors. Recent studies have discovered circRNAs can perform as gene regulators in diversified physiological and pathological processes and can regulate tumorigenesis and cancer progression (Li et al., 2020). Meanwhile, circRNAs have also been clarified to exert biological functions by performing as miRNA sponges or protein sponges (van Zonneveld et al., 2021). Therefore, circRNAs have been identified as latent biomarkers for tumor diagnosis (Zhu et al., 2021). Circ-CSPP1 is a newly identified circRNA that has been confirmed to take on a momentous role in tumorigenesis (Xue, 2020; Sun et al., 2020). However, its role in RCC and its latent mechanisms remain uncertain.

MicroRNAs (miRNAs) are a class of single-stranded non-coding RNAs that post-transcriptionally control gene expression (Bushati et al., 2007). miRNA dysregulation is the key to the pathogenesis of diversified diseases, including cancer (Ali Syeda et al., 2020) and can function as latent oncogenes or tumor suppressor genes (Iorio et al., 2012). For instance, miR-133b impacts cell proliferation, chemosensitivity, and invasion of RCC cells by refraining the ERK signaling pathway (Xu et al., 2020). A former study clarified that miR-493-5p expression is reduced in hepatocellular carcinoma (HCC) (Yang et al., 2021). However, miR-493-5p’s functions in RCC and its interaction with circ-CSPP1 remain ambiguous.

Ras-related C3 botulinum toxin substrate 1 (RAC1) is also commonly present in mammalian tissues and cells as a multiplex regulator of epithelial differentiation and is involved in apoptosis-related pathways through the production of reactive oxygen species (Lee et al., 2012). RAC1 has been implicated in multiple cellular processes, such as cell proliferation, tumor metastasis, and epithelial-mesenchymal transition (Yoon et al., 2017). The same pathways shared by circRNAs, miRNAs, and RAC1 suggest that they might function coordinately to orchestrate tumorigenesis. RAC1 has been reported to contribute to the tumorigenesis of RCC (Zhang, 2022; Shan et al., 2017). Thus, RAC1 could be the target gene of miRNAs to regulate the tumorigenesis of RCC.

This study was conducted to figure out the biological characteristics and latent mechanisms of circ-CSPP1 in RCC progression and Warburg effect. Circ-CSPP1 motivated RCC progression and the Warburg effect by targeting miR-493-5p to control RAC1, suggesting that circ-CSPP1 may offer a novel biomarker and latent therapeutic target for RCC.

Materials and methods

Clinical sample collection

The research was approved by the Ethics Committee of The Second Affiliated Hospital of Xi’an Jiaotong University (Approval number.201803XAHT), and informed consent was obtained from each subject before sample collection. Forty pairs of RCC tumor tissues and adjacent normal tissues were harvested from patients in the urology department at The Second Affiliated Hospital of Xi’an Jiaotong University, and two pathologists independently made a definite pathological diagnosis. Adjacent normal tissue was harvested at least 3 cm from the tumor site. Tissues were kept in liquid nitrogen. Clinical data including clinical stage, age, gender, tumor stage, lymph node metastasis, and distant metastasis were recorded.

Cell culture

RCC cell lines (786-O, ACHN, CAKI-1, and OSRC2) and human normal kidney cell line (HK-2) were bought from the Chinese Academy of Sciences (Shanghai, China). Cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium plus 10% fetal bovine serum (Gibco, Carlsbad, CA, USA), 100 units (U)/ml penicillin, and 100 U/ml streptomycin (Gibco).

Cell transfection

Transfection of miRNA mimics, inhibitors, small interfering RNAs (siRNAs), and plasmids was done with Lipofectamine 3000 (Invitrogen, Carlsbad, CA) in the light of the manufacturer’s instructions. MiR-493-5p mimic, miR-493-5p inhibitor, circ-CSPP1 siRNA (si-circ-CSPP1), RAC1 siRNA (si-RAC1) and their negative controls (NCs) were bought from GenePharma (Shanghai, China). pcDNA 3.1 circRNA mini vector was utilized to elevate circ-CSPP1 expression in RCC cells.

Cell counting kit (CCK)-8 assay

Transfected cells were seeded in 96-well plates (Gibco BRL, Gaithersburg, MD, USA). Measurement of optical density at 450 nm was done with a microplate reader (Millipore, Billerica, MA, USA) (Chen et al., 2020).

Colony formation assay

Transfected cells were seeded in 6-well plates and cultivated for colony formation assay. The colonies were fixed with 4% formaldehyde (Macklin, Shanghai, China), and then staining with 0.3% crystal violet was implemented. Counting and analyzing visible colonies were done by Image J software 1.8.0 (Wang et al., 2020).

Flow cytometry

Apoptosis was tested by Annexin V- fluorescein isothiocyanate/propidium iodide (PI) apoptosis detection kit (Invitrogen). Briefly, double-staining was done with Annexin V and PI, and then the apoptosis rate was examined via FACSCalibur (Becton Dickinson) and FlowJo 10.0 software (Lin et al., 2020).

Transwell assays

For cell invasion assay, transfected cells were seeded into 24-well transwell chambers with Matrigel. After incubation, non-invasive cells were wiped off, invasive cells were fixed with paraformaldehyde, and then staining with crystal violet was implemented. Counting and photographing stained cells in each well were conducted under an inverted microscope (Olympus, Japan). As for the migration experiment, cells were seeded into the upper chamber without Matrigel, and other steps were similar to the cell invasion experiments.

Lactate production, glucose uptake, and ATP

Quantification of glucose levels was done using a glucose assay kit (Sigma-Aldrich, St. Louis, MO, USA). Measurement of lactate levels was implemented using a lactate assay kit (BioVision, Mountain View, CA, USA). ATP levels were tested by the CellTiter-Glo fluorescent cell viability assay (Promega, Madison, MI, USA).

Reverse transcription quantitative polymerase chain reaction (RT-qPCR)

Total RNA was extracted from tissues or cells using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol. cDNA was generated using the Promega reverse transcription kit. RT-qPCR was carried out in the ABI7500 system using the SYBR Green method. Relative gene expression was determined by the 2-ΔΔct method. The primers were clarified in Table 1 (Cao et al., 2020).

Western blot

RIPA lysis buffer (Beyotime) was used to extract total protein. Proteins were separated by 12% Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electro-blotted onto polyvinylidene fluoride membranes. The membranes were incubated with primary antibodies RAC1 (05-389, 1:1000, MilliporeSigma) and GAPDH (2118, 1:1000, Cell Signaling Technology). Bands were visualized via enhanced chemiluminescence (Millipore) after incubation with the HRP-conjugated secondary antibody. Relative band intensities were quantified by the ChemiDoc XRS imaging system (Liu et al., 2020).

Luciferase activity assay

After predicting the binding sites of circ-CSPP1 and RAC1 3’UTR in miR-493-5p, pmirGLO reporter vector (Promega) was utilized to construct circ-CSPP1 and RAC1 3’UTR wild-type (WT) and Mutant (MUT) reporter vectors. A549 cells were incubated with miR-545-5p mimic or mimic NC with the reporter vectors. Then cell luciferase activity was tested by the dual luciferase reporter gene detection kit (Promega) (Yuan et al., 2021).

Statistics

All data were processed by SPSS 21.0 statistical software (SPSS, Inc, Chicago, IL, USA). Measurement data were shown as mean ± standard deviation (S.D.). For the measurement data obeyed a normal distribution, a t-test was used for comparison between the two groups, and a one-way analysis of variance and the Bonferroni post-hoc test were used for comparison among multiple groups. To evaluate the relationship between circ-CSPP1 and the survival prognosis of RCC patients, the Kaplan-Meier method was used for survival analysis, and a log-rank test was used to determine that the difference between high and low expression curves was statistically significant. Pearson correlation analysis in clinical samples was conducted. P<0.05 emphasized obvious statistical meaning.

Results

Circ-CSPP1 is elevated in RCC and is associated with poor prognosis

Circ-CSPP1 was up-regulated in RCC tissues (Fig. 1A). Endogenous circ-CSPP1 was elevated in RCC cell lines, and highest in ACHN cells (Fig. 1B). Therefore, ACHN cells were chosen for subsequent experiments. The 40 patients were divided into two groups according to circ-CSPP1 expression, and circ-CSPP1 was associated with distant metastasis, clinical stage, and tumor stage (Table 2). Meanwhile, it came out that clinical stage, tumor stage, distant metastasis, and circ-CSPP1 were independent predictors of overall survival (OS) of RCC patients (Table 3). Kaplan-Meier survival analysis exhibited that RCC patients with higher circ-CSPP1 expression had poor OS (Fig. 1C). These results suggested that circ-CSPP1 is elevated in RCC and is associated with poor prognosis.

Circ-CSPP1 motivates RCC progression and glycolysis

For studying the biological function of circ-CSPP1 in RCC, si-circ-CSPP1, pcDNA3.1-circ-CSPP1, and corresponding NCs were introduced into ACHN cells, and the transfection efficiency was verified (Fig. 2A). The results clarified that repression of circ-CSPP1 restrained cell proliferation, invasion, and migration, and induced apoptosis, but elevation of circ-CSPP1 had the opposite effect (Fig. 2B–F). Meanwhile, Warburg effect correlation analysis clarified that suppressing circ-CSPP1 reduced lactate production, glucose uptake, and ATP, while up-regulation of circ-CSPP1 resulted in the opposite results (Fig. 2G–I). In addition, similar results were found in KAKi-1 cells (Supplementary Fig. 1A–I at https://ojs.ptbioch.edu.pl/index.php/abp). These data suggested that circ-CSPP1 motivated RCC progression and glycolysis.

Circ-CSPP1 adsorbs miR-493-5p in RCC

The targeting sites for circ-CSPP1 and miR-493-5p were predicted by starBase (Fig. 3A). Luciferase activity assay was performed to testify the binding relationship between circ-CSPP1 and miR-493-5p, and it came out that circ-CSPP1-WT with miR-493-5p mimic reduced luciferase activity, indicating that circ-CSPP1 could combine with miR-493-5p (Fig. 3B). As expected, depression of circ-CSPP1 elevated miR-493-5p expression in ACHN cells, whereas upregulating circ-CSPP1 suppressed miR-493-5p expression (Fig. 3C). Moreover, it was discovered that circ-CSPP1 was inversely correlated with miR-493-5p expression in RCC tissues (Fig. 3D–E). Taken together, these findings suggested that circ-CSPP1 adsorbed miR-493-5p in RCC.

MiR-493-5p represses RCC progression and glycolysis

For studying miR-493-5p’s biological function in RCC, miR-493-5p mimic, miR-493-5p inhibitor and corresponding NCs were introduced into ACHN cells, and the transfection efficiency was testified (Fig. 4A). It turned out that elevating miR-493-5p refrained cell progression while repressing miR-493-5p had the opposite effect (Fig. 4B–F). The Warburg effect correlation analysis clarified that elevation of miR-493-5p reduced ATP, glucose uptake and lactate production, while depression of miR-493-5p caused the opposite results (Fig. 4G–I). These results suggested that miR-493-5p depressed RCC progression and glycolysis.

RAC1 is miR-493-5p’s downstream target in RCC

starBase was applied for predicting that miR-493-5p had a targeted binding site with RAC1 (Fig. 5A). RAC1 expression was elevated in RCC tissues (Fig. 5B), and miR-493-5p was inversely linked with RAC1 expression in RCC tissues (Fig. 5C). Furthermore, it was found that miR-493-5p mimic could reduce RAC1 expression, whereas miR-493-5p inhibitor could elevate RAC1 expression (Fig. 5D). In the luciferase activity assay, it was found that the luciferase activity was suppressed after introduction of RAC1-WT and miR-493-5p mimic (Fig. 5E). All in all, RAC1 was miR-493-5p’s downstream target in RCC.

Circ-CSPP1 accelerates RCC progression and glycolysis through the miR-493-5p/RAC1 axis

After verifying that RAC1 is the target of miR-493-5p, we investigated whether circ-CSPP1 accelerates the development of RCC by controlling the miR-493-5p/RAC1 axis. It was found that upregulation of circ-CSPP1 elevated RAC1 expression, and repression of RAC1 restored RAC1 expression following upregulation of circ-CSPP1 (Fig. 6A). It turned out that repression of RAC1 abolished the motivation of cell proliferation by elevation of circ-CSPP1 (Fig. 6B, C). Likewise, the repressive effect of up-regulated circ-CSPP1 on apoptosis was abolished by down-regulated RAC1 (Fig. 6D). Moreover, RAC1 repression attenuated the promoting effect of circ-CSPP1 upregulation on cell invasion and migration (Fig. 6E, F). Also, repression of RAC1 could turn around the motivation of cellular glycolysis by up-regulation of circ-CSPP1 (Fig. 6G-I). Taken together, these data suggested that circ-CSPP1 motivated RCC progression and glycolysis through the miR-493-5p/RAC1 axis.

Discussion

CircRNAs are extensively studied cancer markers recently (Yan et al., 2021). More studies have shown that circRNA takes on a crucial role in the genesis and progression of diversified tumors. For example, hsa_circ_0065217 is elevated in RCC and motivates RCC growth and metastasis via controlling the miR-214-3p-ALPK2 axis (Zhang et al., 2021). Circ_001842 is elevated in RCC and exerts an oncogenic role in RCC via a miR-502-5p-dependent SLC39A14 mechanism (Zeng et al., 2020). Our research revealed that circ-CSPP1 was upregulated in RCC tissues, and RCC patients with high circ-CSPP1 expression had a poor prognosis, suggesting that circ-CSPP1 may be a prognostic biomarker for RCC patients. Meanwhile, circ-CSPP1 silencing restrained RCC cell progression in vitro, while elevation of circ-CSPP1 showed opposite results. These data suggested that circ-CSPP1 motivated the progression of RCC.

It is well known that mammalian cells generate energy through oxidative phosphorylation under aerobic conditions, and during tumorigenesis, cancer cells must rewire their metabolism to maintain survival and reproduction (Urbano et al., 2021). Most cancer cells utilize the Warburg effect to support anabolic growth and tumorigenesis, namely aerobic glycolysis, a metabolic mode that is favored even in the presence of oxygen (Lundø et al., 2020). Warburg effect was found to be beneficial for cancer cell progression and was involved in immune responses and drug resistance (Samec, 2020; Icard et al., 2018). Recent studies have shown that circRNAs can modulate tumor phenotypes, such as metastasis and the Warburg effect. For example, circFOXP1 motivates RCC progression and Warburg effect by sponging miR-423-5p to upregulate U2AF2 (Fang et al., 2021). This study identified a novel circRNA as a regulator of the Warburg effect. The results clarified that downregulation of circ-CSPP1 suppressed the Warburg effect in RCC cells.

Several studies have shown that circ-CSPP1 performs as an oncogene in diversified human cancers and exerts its biological functions by adsorbing miRNAs. For example, circ-CSPP1 is elevated in cervical cancer (CC), and circ-CSPP1 knockdown suppresses CC tumor growth and migration via downregulating ITGB1, PI3K and Akt expression by sponging miR-361-5p (Yang et al., 2020). Circ-CSPP1 is upregulated in ovarian cancer (OC), and silencing circ-CSPP1 represses OC cell biological functions via upregulating miR-1236-3p (Li et al., 2019). Here, it was confirmed that circ-CSPP1 was a decoy of miR-493-5p. Furthermore, repressing miR-493-5p turned around the effect of circ-CSPP1 silencing on RCC cell progression and Warburg effect, while elevating miR-493-5p turned around the effect of upregulating circ-CSPP1 on RCC progression and Warburg effect in HCC. These results suggested that circ-CSPP1 controlled RCC progression and the Warburg effect via performing as a sponge for miR-493-5p.

MiRNAs control gene expression by combining with mRNAs’ 3’-UTR, thereby regulating diversified aspects of cellular activity (Huang et al., 2011). Here, RAC1 was a target of miR-493-5p. RAC1 is a highly conserved rho family small GTPase that is essential for diversified cellular and developmental processes (Banka et al., 2022). RAC1 is elevated in different types of tumors, including RCC, and motivates tumorigenesis by participating in tumor cell biological behaviors (Liang et al., 2021; Goka et al., 2020). This study also confirmed that RAC1 was elevated in RCC tissues, and its expression was up-regulated by elevation of circ-CSPP1 but refrained by upregulation of miR-493-5p. Moreover, repression of RAC1 clearly turned around the effect of circ-CSPP1 elevation on RCC cell progression and the Warburg effect. These results suggested that circ-CSPP1 motivated RCC progression and glycolysis through miR-493-5p/RAC1 axis.

However, the research still takes on several limitations. Although the role of circ-CSPP1 in RCC progression has been partially elucidated, the study had a small sample size, and more tissue samples are still needed to further examine circ-CSPP1 expression trend in RCC. Also, further animal experiments are required to validate the effect of the circ-CSPP1/miR-493-5p/RAC1 axis on RCC tumor growth in vivo. Moreover, the Crabtree effect (inhibitory effect of high glucose on mitochondrial oxidative phosphorylation) may also exist in cancer cells. In other words, under the condition of high glucose concentration, glycolytic metabolism is dominated in cells while aerobic respiration is inhibited, thus generating lactic acid (Diaz et al., 2011; Redman et al., 2013). The Crabtree effect is similar to the Warburg effect, the only difference being that the Crabtree effect is caused by high concentrations of glucose (Hammad et al., 2016), therefore, in future studies, exogenous glucose concentration will be a parameter that needs to be designed more precisely to exclude the interference of Crabtree effect as much as possible.

Conclusion

All in all, circ-CSPP1 motivates RCC progression and the Warburg effect by acting as a miR-493-5p sponge to upregulate RAC1. The study findings suggest that circ-CSPP1 may serve as a hopeful diagnostic and therapeutic target for RCC.

Declarations

Acknowledgments. Not applicable.

Competing interests. The authors have no conflicts of interest to declare.

References

Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ (2020) Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci 21. https://doi.org/10.3390/ijms21051723

Banka S, Bennington A, Baker MJ, Rijckmans E, Clemente GD, Ansor NM, Sito H, Prasad P, Anyane-Yeboa K, Badalato L, Dimitrov B, Fitzpatrick D, Hurst ACE, Jansen AC, Kelly MA, Krantz I, Rieubland C, Ross M, Rudy NL, Sanz J, Stouffs K, Xu ZL, Malliri A, Kazanietz MG, Millard TH (2022) Activating RAC1 variants in the switch II region cause a developmental syndrome and alter neuronal morphology. Brain 145: 4232–4245. https://doi.org/10.1093/brain/awac049

Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23: 175–205. https://doi.org/10.1146/annurev.cellbio.23.090506.123406

Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y, Qiu S, Li L, Karamfilova Zaharieva E, Zhou X, Xu Y (2020) Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis 11: 145. https://doi.org/10.1038/s41419-020-2336-0

Chen L, Wu D, Ding T (2020) Circular RNA circ_0001368 inhibited growth and invasion in renal cell carcinoma by sponging miR-492 and targeting LATS2. Gene 753: 144781. https://doi.org/10.1016/j.gene.2020.144781

Diaz-Ruiz R, Rigoulet M, Devin A (2011) The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta 1807: 568–576. https://doi.org/10.1016/j.bbabio.2010.08.010

Emberley E, Pan A, Chen J, Dang R, Gross M, Huang T, Li W, MacKinnon A, Singh D, Sotirovska N, Steggerda SM, Wang T, Parlati F (2021) The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma. PLoS One 16: e0259241. https://doi.org/10.1371/journal.pone.0259241

Fang L, Ye T, An Y (2021) Circular RNA FOXP1 induced by ZNF263 upregulates U2AF2 expression to accelerate renal cell carcinoma tumorigenesis and warburg effect through sponging miR-423-5p. J Immunol Res 2021: 8050993. https://doi.org/10.1155/2021/8050993

Goka ET, Chaturvedi P, Lopez DTM, Lippman ME (2020) Rac Signaling drives clear cell renal carcinoma tumor growth by priming the tumor microenvironment for an angiogenic switch. Mol Cancer Ther 19: 1462–1473. https://doi.org/10.1158/1535-7163.mct-19-0762

Hammad N, Rosas-Lemus M, Uribe-Carvajal S, Rigoulet M, Devin A (2016) The Crabtree and Warburg effects: Do metabolite-induced regulations participate in their induction? Biochim Biophys Acta 1857: 1139–1146. https://doi.org/10.1016/j.bbabio.2016.03.034

Huang A, Zheng H, Wu Z, Chen M, Huang Y (2020) Circular RNA-protein interactions: functions, mechanisms, and identification. Theranostics 10: 3503–3517. https://doi.org/10.7150/thno.42174

Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ (2011) Biological functions of microRNAs: a review. J Physiol Biochem 67: 129–139. https://doi.org/10.1007/s13105-010-0050-6

Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H (2018) How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat 38: 1–11. https://doi.org/10.1016/j.drup.2018.03.001

Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143–159. https://doi.org/10.1002/emmm.201100209

Lee NH, Chang JW, Choi J, Jung HH, Im GJ (2013) Expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) in human cholesteatoma. Eur Arch Otorhinolaryngol 270: 455–459. https://doi.org/10.1007/s00405-012-1966-y

Li QH, Liu Y, Chen S, Zong ZH, Du YP, Sheng XJ, Zhao Y (2019, Jun) circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Biomed Pharmacother 114: 108832. https://doi.org/10.1016/j.biopha.2019.108832

Li R, Luo S, Zhang D (2020) Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway. Gene 754: 144811. https://doi.org/10.1016/j.gene.2020.144811

Liang J, Oyang L, Rao S, Han Y, Luo X, Yi P, Lin J, Xia L, Hu J, Tan S, Tang L, Pan Q, Tang Y, Zhou Y, Liao Q (2021) Rac1, A potential target for tumor therapy. Front Oncol 11: 674426. https://doi.org/10.3389/fonc.2021.674426

Lin L, Cai J (2020, Nov) Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation. J Cell Biochem 121: 4377–4385. https://doi.org/10.1002/jcb.29620

Liu G, Zhou J, Piao Y, Zhao X, Zuo Y, Ji Z (2020) Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis. Aging (Albany NY) 12: 11530–11549. https://doi.org/10.18632/aging.103300

Lundø K, Trauelsen M, Pedersen SF, Schwartz TW (2020) Why Warburg works: lactate controls immune evasion through GPR81. Cell Metab 31: 666–668. https://doi.org/10.1016/j.cmet.2020.03.001

Redman EK, Brookes PS, Karcz MK (2013) Role of p90(RSK) in regulating the Crabtree effect: implications for cancer. Biochem Soc Trans 41: 124–126. https://doi.org/10.1042/bst20120277

Rysz J, Franczyk B, Ławiński J, Gluba-Brzózka A (2021) Characteristics of clear cell papillary renal cell carcinoma (ccpRCC). Int J Mol Sci 23. https://doi.org/10.3390/ijms23010151

Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, Varghese E, Abotaleb M, Qaradakhi T, Zulli A, Kello M, Mojzis J, Zubor P, Kwon TK, Shakibaei M, Büsselberg D, Sarria GR, Golubnitschaja O, Kubatka P (2020) Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. Epma J 11: 377–398. https://doi.org/10.1007/s13167-020-00217-y

Shan G, Tang T, Qian H, Xia Y (2017) Expression of Tiam1 and Rac1 proteins in renal cell carcinoma and its clinical-pathological features. Int J Clin Exp Pathol 10: 11114–11121

Sun Q, Yu R, Wang C, Yao J, Zhang L (2020) Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577. Cancer Cell Int 20: 202. https://doi.org/10.1186/s12935-020-01287-8

Urbano AM (2021) Otto Warburg: The journey towards the seminal discovery of tumor cell bioenergetic reprogramming. Biochim Biophys Acta Mol Basis Dis 1867: 165965. https://doi.org/10.1016/j.bbadis.2020.165965

van Zonneveld AJ, Kölling M, Bijkerk R, Lorenzen JM (2021) Circular RNAs in kidney disease and cancer. Nat Rev Nephrol 17: 814–826. https://doi.org/10.1038/s41581-021-00465-9

Wang X, Shi J, Niu Z, Wang J, Zhang W (2020) MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2. Biosci Biotechnol Biochem 84: 2014–2027. https://doi.org/10.1080/09168451.2020.1783197

Xu Y, Ma Y, Liu XL, Gao SL (2020) miR-133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway. Mol Med Rep 22: 67–76. https://doi.org/10.3892/mmr.2020.11125

Xue YF, Li M, Li W, Lin Q, Yu BX, Zhu QB, Chen HJ (2020) Roles of circ-CSPP1 on the proliferation and metastasis of glioma cancer. Eur Rev Med Pharmacol Sci 24: 5519–5525. https://doi.org/10.26355/eurrev_202005_21337

Yan JS, Chen Q, Li YL, Gao YQ (2021) Hsa_circ_0065217 promotes growth and metastasis of renal cancer through regulating the miR-214-3p-ALPK2 axis. Cell Cycle 20: 2519–2530. https://doi.org/10.1080/15384101.2021.1991123

Yang G, Xu Q, Wan Y, Zhang L, Wang L, Meng F (2021) Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation. Cell Signal 86: 110065. https://doi.org/10.1016/j.cellsig.2021.110065

Yang W, Xie T (2020, Jan) Hsa_circ_CSPP1/MiR-361-5p/ITGB1 regulates proliferation and migration of cervical cancer (CC) by modulating the PI3K-Akt signaling pathway. Reprod Sci 27: 132–144. https://doi.org/10.1007/s43032-019-00008-5

Yoon C, Cho SJ, Chang KK, Park DJ, Ryeom SW, Yoon SS (2017) Role of Rac1 pathway in epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes in gastric adenocarcinoma. Mol Cancer Res 15: 1106–1116. https://doi.org/10.1158/1541-7786.mcr-17-0053

Yuan Y, Zhou X, Kang Y, Kuang H, Peng Q, Zhang B, Liu X, Zhang M (2021) Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis. Life Sci 267: 118955. https://doi.org/10.1016/j.lfs.2020.118955

Zeng J, Feng Q, Wang Y, Xie G, Li Y, Yang Y, Feng J (2020) Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14. J Cell Mol Med 24: 9712–9725. https://doi.org/10.1111/jcmm.15529

Zhang Y, Chen M, Liu M, Xu Y, Wu G (2021) Glycolysis-related genes serve as potential prognostic biomarkers in clear cell renal cell carcinoma. Oxid Med Cell Longev 2021: 6699808. https://doi.org/10.1155/2021/6699808

Zhang Y, Zhang H, Han Z, Wang X, Li X, Yuan P, Ji S, Liu Q (2022) A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1. Exp Ther Med 24: 558. https://doi.org/10.3892/etm.2022.11489

Zhu G, Chang X, Kang Y, Zhao X, Tang X, Ma C, Fu S (2021) CircRNA: A novel potential strategy to treat thyroid cancer (Review) Int J Mol Med 48. https://doi.org/10.3892/ijmm.2021.5034